GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curocell Inc (XKRX:372320) » Definitions » Sale Of Investment

Curocell (XKRX:372320) Sale Of Investment : ₩ Mil (TTM As of Jun. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Curocell Sale Of Investment?

Curocell's sale of investment for the six months ended in Jun. 2023 was ₩42,400.00 Mil. It means Curocell gained ₩42,400.00 Mil from selling investments.

Compared with last quarter (₩61,000.00 Mil in Dec. 2022 ), Curocell gained less money from selling investments in Jun. 2023 (₩42,400.00 Mil).


Curocell Sale Of Investment Historical Data

The historical data trend for Curocell's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curocell Sale Of Investment Chart

Curocell Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Investment
10,799.80 7,000.00 75,101.25 82,800.00 57,400.00

Curocell Semi-Annual Data
Jun22 Dec22 Jun23 Dec23
Sale Of Investment 21,800.00 61,000.00 42,400.00 15,000.00

Curocell Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.


Curocell Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Curocell's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Curocell (XKRX:372320) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
11, Gukjegwahak 16-ro, Yuseong-gu, Daejeon, KOR, 34002
Curocell Inc is engaged in medical and pharmaceutical research and development. The company is into development of CAR-T treatments that enhance the natural function of immune cells to eliminate cancer cells through genetic manipulation of human immune cells.

Curocell (XKRX:372320) Headlines

No Headlines